Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 5
Out of 5,170 analysts
139
Total ratings
63.27%
Success rate
153.97%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DGX Quest Diagnostics | Maintains: Buy | $215 → $220 | $194.16 | +13.31% | 4 | Feb 11, 2026 | |
| RVTY Revvity | Maintains: Hold | $100 → $105 | $85.76 | +22.43% | 2 | Feb 3, 2026 | |
| DHR Danaher | Maintains: Overweight | $270 → $275 | $190.11 | +44.65% | 5 | Jan 29, 2026 | |
| AVTR Avantor | Downgrades: Underperform | $12 → $9 | $7.61 | +18.27% | 1 | Dec 17, 2025 | |
| BLLN BillionToOne | Initiates: Hold | $117 | $74.00 | +58.11% | 1 | Dec 1, 2025 | |
| WAT Waters | Maintains: Buy | $435 → $385 | $299.57 | +28.52% | 8 | Aug 4, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $111.75 | +38.70% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $73.00 | +9.59% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $16.57 | +165.54% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,190.49 | -7.60% | 8 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $290 | $264.09 | +9.81% | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $8.18 | +168.95% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $75.33 | +12.84% | 7 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $41 → $53 | $40.65 | +30.31% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $44.80 | -21.88% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $18.38 | +30.58% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.40 | +185.71% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $2.75 | +9.09% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $202.73 | -29.96% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $89.08 | -64.08% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $126.59 | -9.16% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $4.75 | +321.05% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $470.21 | +38.24% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $13.56 | -33.63% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.50 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $1.73 | +595.65% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $4.41 | +1,260.54% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $4.86 | +373.25% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $153.05 | +154.82% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $2.91 | +518.56% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $479.93 | -58.33% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $25.26 | -4.99% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $11.26 | +299.64% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $117.61 | -40.48% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $166.47 | -27.91% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $0.43 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $33.63 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $7.89 | +597.08% | 1 | Jul 19, 2016 |
Quest Diagnostics
Feb 11, 2026
Maintains: Buy
Price Target: $215 → $220
Current: $194.16
Upside: +13.31%
Revvity
Feb 3, 2026
Maintains: Hold
Price Target: $100 → $105
Current: $85.76
Upside: +22.43%
Danaher
Jan 29, 2026
Maintains: Overweight
Price Target: $270 → $275
Current: $190.11
Upside: +44.65%
Avantor
Dec 17, 2025
Downgrades: Underperform
Price Target: $12 → $9
Current: $7.61
Upside: +18.27%
BillionToOne
Dec 1, 2025
Initiates: Hold
Price Target: $117
Current: $74.00
Upside: +58.11%
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $299.57
Upside: +28.52%
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $111.75
Upside: +38.70%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $73.00
Upside: +9.59%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $16.57
Upside: +165.54%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,190.49
Upside: -7.60%
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $264.09
Upside: +9.81%
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $8.18
Upside: +168.95%
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $75.33
Upside: +12.84%
Dec 10, 2024
Assumes: Buy
Price Target: $41 → $53
Current: $40.65
Upside: +30.31%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $44.80
Upside: -21.88%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $18.38
Upside: +30.58%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.40
Upside: +185.71%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $2.75
Upside: +9.09%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $202.73
Upside: -29.96%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $89.08
Upside: -64.08%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $126.59
Upside: -9.16%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $4.75
Upside: +321.05%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $470.21
Upside: +38.24%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $13.56
Upside: -33.63%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.50
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.73
Upside: +595.65%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $4.41
Upside: +1,260.54%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $4.86
Upside: +373.25%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $153.05
Upside: +154.82%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $2.91
Upside: +518.56%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $479.93
Upside: -58.33%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $25.26
Upside: -4.99%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $11.26
Upside: +299.64%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $117.61
Upside: -40.48%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $166.47
Upside: -27.91%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $0.43
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $33.63
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $7.89
Upside: +597.08%